Evidence map›Paper›PMID 33735112›Full record

ArticleJCI insight2021

Identification of a series of hair-cell MET channel blockers that protect against aminoglycoside-induced ototoxicity.

Emma J Kenyon, Nerissa K Kirkwood, Siân R Kitcher, Richard J Goodyear, Marco Derudas, Daire M Cantillon, Sarah Baxendale, Antonio de la Vega de León, Virginia N Mahieu, Richard T Osgood and 7 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. SKOOTS: Skeleton-oriented object segmentation for mitochondria.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in pharmacology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Emma J KenyonSussex Neuroscience and.
Nerissa K KirkwoodSussex Neuroscience and.
Siân R KitcherSussex Neuroscience and.
Richard J GoodyearSussex Neuroscience and.
Marco DerudasSussex Drug Discovery Centre, School of Life Sciences, and.
Daire M CantillonGlobal Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
Sarah BaxendaleBateson Centre and Department of Biomedical Science, and.
Antonio de la Vega de LeónInformation School, University of Sheffield, Sheffield, United Kingdom.
Virginia N MahieuSussex Neuroscience and.
Richard T OsgoodSussex Neuroscience and.
Charlotte Donald WilsonSussex Neuroscience and.
James C BullDepartment of Biosciences, College of Science, Swansea University, Swansea, United Kingdom.
Simon J WaddellGlobal Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
Tanya T WhitfieldBateson Centre and Department of Biomedical Science, and.
Simon E WardMedicines Discovery Institute, Cardiff University, Cardiff, United Kingdom.
Corné J KrosSussex Neuroscience and.
Guy P RichardsonSussex Neuroscience and.
Sussex County Community College · USBrighton and Sussex Medical School · GBCardiff University · GBDiscovery Centre · CASwansea University · GBUniversity of Sheffield · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J003050/1Biotechnology and Biological Sciences Research Council BB/S007008/1Medical Research Council G0802527Medical Research Council MR/K005561/1Wellcome TrustWellcome Trust 204833/Z/16/A
6 · The paper itself

Abstract

To identify small molecules that shield mammalian sensory hair cells from the ototoxic side effects of aminoglycoside antibiotics, 10,240 compounds were initially screened in zebrafish larvae, selecting for those that protected lateral-line hair cells against neomycin and gentamicin. When the 64 hits from this screen were retested in mouse cochlear cultures, 8 protected outer hair cells (OHCs) from gentamicin in vitro without causing hair-bundle damage. These 8 hits shared structural features and blocked, to varying degrees, the OHC's mechano-electrical transducer (MET) channel, a route of aminoglycoside entry into hair cells. Further characterization of one of the strongest MET channel blockers, UoS-7692, revealed it additionally protected against kanamycin and tobramycin and did not abrogate the bactericidal activity of gentamicin. UoS-7692 behaved, like the aminoglycosides, as a permeant blocker of the MET channel; significantly reduced gentamicin-Texas red loading into OHCs; and preserved lateral-line function in neomycin-treated zebrafish. Transtympanic injection of UoS-7692 protected mouse OHCs from furosemide/kanamycin exposure in vivo and partially preserved hearing. The results confirmed the hair-cell MET channel as a viable target for the identification of compounds that protect the cochlea from aminoglycosides and provide a series of hit compounds that will inform the design of future otoprotectants.

Indexed as

AminoglycosidesAnimalsCochleaDrug Evaluation, PreclinicalEmbryo, NonmammalianFemaleGentamicinsHair Cells, AuditoryMaleMechanotransduction, CellularMiceMice, Inbred StrainsMicrobial Sensitivity TestsMicrophthalmia-Associated Transcription FactorNeomycinOrgan Culture TechniquesAminoglycosidesGentamicinsMicrophthalmia-Associated Transcription Factormitfa protein, zebrafishNeomycinProtective AgentsZebrafish ProteinsDrug screensMouse modelsNeuroscienceTherapeutics

Identifiers

PMID33735112
PMCPMC8133782
OpenAlexW3136807286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.